Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miklos Marosfoi

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Neurointerventional Surgery|July 10, 2017
Acute thrombus formation on phosphorilcholine surface modified flow divertersMiklos Marosfoi, Frederic Clarencon, Erin T Langan, et al.
Journal of Neurointerventional Surgery|August 1, 2019
Focal cooling of brain parenchyma in a transient large vessel occlusion model: proof-of-conceptJildaz Caroff, Robert M King, Jennifer E Mitchell, et al.
Neuroradiology|December 25, 2015
Safety, efficacy, and short-term follow-up of the use of Pipeline Embolization Device in small (<2.5 mm) cerebral vessels for aneurysm treatment: single institution experienceAjit S Puri, Francesco Massari, Takumi Asai, et al.
Journal of Neurointerventional Surgery|May 13, 2022
Treatment of large and giant posterior communicating artery aneurysms with the Surpass streamline flow diverter: results from the SCENT trialPeter Kan, Alina Mohanty, Philip M Meyers, et al.
Journal of Neurointerventional Surgery|March 8, 2018
Phosphorylcholine surface modified flow diverter associated with reduced intimal hyperplasiaJildaz Caroff, Takamitsu Tamura, Robert M King, et al.
Journal of Neurointerventional Surgery|October 7, 2016
In situ tissue engineering: endothelial growth patterns as a function of flow diverter designMiklos Marosfoi, Erin T Langan, Lara Strittmatter, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 26, 2024
Quantifying and mitigating motor phenotypes induced by antisense oligonucleotides in the central nervous systemMichael P Moazami, Julia M Rembetsy-Brown, Samantha L Sarli, et al.
Nature Medicine|December 24, 2021
Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotideHélène Tran, Michael P Moazami, Huiya Yang, et al.
Journal of Neurosurgery|July 11, 2015
Neuroophthalmological outcomes associated with use of the Pipeline Embolization Device: analysis of the PUFS trial resultsDaniel H Sahlein, Mohammad Fouladvand, Tibor Becske, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Neurointerventional Surgery|July 10, 2017
Acute thrombus formation on phosphorilcholine surface modified flow divertersMiklos Marosfoi, Frederic Clarencon, Erin T Langan, et al.
Journal of Neurointerventional Surgery|August 1, 2019
Focal cooling of brain parenchyma in a transient large vessel occlusion model: proof-of-conceptJildaz Caroff, Robert M King, Jennifer E Mitchell, et al.
Neuroradiology|December 25, 2015
Safety, efficacy, and short-term follow-up of the use of Pipeline Embolization Device in small (<2.5 mm) cerebral vessels for aneurysm treatment: single institution experienceAjit S Puri, Francesco Massari, Takumi Asai, et al.
Journal of Neurointerventional Surgery|May 13, 2022
Treatment of large and giant posterior communicating artery aneurysms with the Surpass streamline flow diverter: results from the SCENT trialPeter Kan, Alina Mohanty, Philip M Meyers, et al.
Journal of Neurointerventional Surgery|March 8, 2018
Phosphorylcholine surface modified flow diverter associated with reduced intimal hyperplasiaJildaz Caroff, Takamitsu Tamura, Robert M King, et al.
Journal of Neurointerventional Surgery|October 7, 2016
In situ tissue engineering: endothelial growth patterns as a function of flow diverter designMiklos Marosfoi, Erin T Langan, Lara Strittmatter, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 26, 2024
Quantifying and mitigating motor phenotypes induced by antisense oligonucleotides in the central nervous systemMichael P Moazami, Julia M Rembetsy-Brown, Samantha L Sarli, et al.
Nature Medicine|December 24, 2021
Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotideHélène Tran, Michael P Moazami, Huiya Yang, et al.
Journal of Neurosurgery|July 11, 2015
Neuroophthalmological outcomes associated with use of the Pipeline Embolization Device: analysis of the PUFS trial resultsDaniel H Sahlein, Mohammad Fouladvand, Tibor Becske, et al.
Pageof 2